Tesamorelin Peptide — GHRH (1-44) Analog | Research Grade (5mg & 10mg)

Tesamorelin is a 44-amino-acid stabilized analog of growth hormone-releasing hormone (GHRH) that is FDA-approved (as Egrifta) for HIV-associated lipodystrophy and is studied in research for visceral fat metabolism and body composition. Research-grade specs Sequence length: 44 amino acids Class: GHRH analog Half-life: ~26 minutes Pharmaceutical equivalent: Egrifta (FDA-approved 2010) Studied applications Visceral adipose tissue research Body-composition and lipid metabolism studies Comparative GHRH-analog research (vs Sermorelin, CJC-1295) Stack research with Ipamorelin (GHRH GHRP) Quality & trust ≥99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included USA same-day shipping (orders before 2pm CT M-F) Related research: Sermorelin · Ipamorelin · Tesamorelin Ipamorelin blend Research literature Tesamorelin has been the subject of 112 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference: Chege BM et al. (2026). Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model. Braz J Med Biol Res. PMID: 42018810 Mendias CL et al. (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID: 41966639 Uçaktürk E et al. (2026). Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry. J Pharm Biomed Anal. PMID: 41138283 Arora G et al. (2026). Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss. J Clin Med. PMID: 41598480 Rahman OF et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200 References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.